149 related articles for article (PubMed ID: 38472983)
1. Correlation of the HPV 16 Genotype Persistence in Women Undergoing LEEP for CIN3 with the Risk of CIN2+ Relapses in the First 18 Months of Follow-Up: A Multicenter Retrospective Study.
Bruno MT; Valenti G; Ruggeri Z; Incognito GG; Coretti P; Montana GD; Panella MM; Mereu L
Diagnostics (Basel); 2024 Feb; 14(5):. PubMed ID: 38472983
[TBL] [Abstract][Full Text] [Related]
2. HPV16 persistent infection and recurrent disease after LEEP.
Bruno MT; Cassaro N; Garofalo S; Boemi S
Virol J; 2019 Nov; 16(1):148. PubMed ID: 31775792
[TBL] [Abstract][Full Text] [Related]
3. Duration of human papillomavirus persistence and its relationship with recurrent cervical dysplasia.
Bogani G; Sopracordevole F; Ciavattini A; Vizza E; Vercellini P; Giannini A; Ghezzi F; Scambia G; Raspagliesi F; Di Donato V;
Eur J Cancer Prev; 2023 Nov; 32(6):525-532. PubMed ID: 37401466
[TBL] [Abstract][Full Text] [Related]
4. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
Zhang G; Yang B; Abdul-Karim FW
Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
[TBL] [Abstract][Full Text] [Related]
5. Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study.
Bogani G; DI Donato V; Sopracordevole F; Ciavattini A; Ghelardi A; Lopez S; Simoncini T; Plotti F; Casarin J; Serati M; Pinelli C; Valenti G; Bergamini A; Gardella B; Dell'acqua A; Monti E; Vercellini P; Fischetti M; D'Ippolito G; Aguzzoli L; Mandato VD; Carunchio P; Carlinfante G; Giannella L; Scaffa C; Falcone F; Borghi C; Ditto A; Malzoni M; Giannini A; Salerno MG; Liberale V; Contino B; Donfrancesco C; Desiato M; Perrone AM; Dondi G; De Iaco P; Leone Roberti Maggiore U; Signorelli M; Chiappa V; Ferrero S; Sarpietro G; Matarazzo MG; Cianci A; Bosio S; Ruisi S; Guerrisi R; Brusadelli C; Mosca L; Tinelli R; DE Vincenzo R; Zannoni GF; Ferrandina G; Petrillo M; Dessole S; Angioli R; Greggi S; Spinillo A; Ghezzi F; Colacurci N; Muzii L; Benedetti Panici P; Scambia G; Raspagliesi F
Gynecol Oncol; 2020 Dec; 159(3):636-641. PubMed ID: 32893030
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus genotyping as a reliable prognostic marker of recurrence after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia (CIN2-3) especially in postmenopausal women.
Kang WD; Kim SM
Menopause; 2016 Jan; 23(1):81-6. PubMed ID: 26057824
[TBL] [Abstract][Full Text] [Related]
7. Age-specific predictors of cervical dysplasia recurrence after primary conization: analysis of 3,212 women.
Bogani G; Pinelli C; Chiappa V; Martinelli F; Lopez S; Ditto A; Raspagliesi F
J Gynecol Oncol; 2020 Sep; 31(5):e60. PubMed ID: 32808492
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
9. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
Song F; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
BMC Cancer; 2022 Jan; 22(1):42. PubMed ID: 34991494
[TBL] [Abstract][Full Text] [Related]
10. Extended Genotyping to Stratify the Risk of CIN2+ in Women with Persistent HPV Infection, Negative Cytology and Type 3 Transformation Zone.
Bruno MT; Valenti G; Cavallaro AG; Palermo I; Aiello T; Farina J; Panella MM; Mereu L
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791895
[TBL] [Abstract][Full Text] [Related]
11. Multiple HPV 16 infection with two strains: a possible marker of neoplastic progression.
Bruno MT; Scalia G; Cassaro N; Boemi S
BMC Cancer; 2020 May; 20(1):444. PubMed ID: 32429930
[TBL] [Abstract][Full Text] [Related]
12. Recurrent high-grade cervical lesion after primary conization is associated with persistent human papillomavirus infection in Norway.
Vintermyr OK; Iversen O; Thoresen S; Quint W; Molijn A; de Souza S; Rosillon D; Holl K
Gynecol Oncol; 2014 May; 133(2):159-66. PubMed ID: 24631451
[TBL] [Abstract][Full Text] [Related]
13. Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women.
Hosaka M; Fujita H; Hanley SJ; Sasaki T; Shirakawa Y; Abiko M; Kudo M; Kaneuchi M; Watari H; Kikuchi K; Sakuragi N
Int J Cancer; 2013 Jan; 132(2):327-34. PubMed ID: 22729477
[TBL] [Abstract][Full Text] [Related]
14. Development of a Nomogram Predicting the Risk of Persistence/Recurrence of Cervical Dysplasia.
Bogani G; Lalli L; Sopracordevole F; Ciavattini A; Ghelardi A; Simoncini T; Plotti F; Casarin J; Serati M; Pinelli C; Bergamini A; Gardella B; Dell'Acqua A; Monti E; Vercellini P; Palaia I; Perniola G; Fischetti M; Santangelo G; Fracassi A; D'Ippolito G; Aguzzoli L; Mandato VD; Giannella L; Scaffa C; Falcone F; Borghi C; Malzoni M; Giannini A; Salerno MG; Liberale V; Contino B; Donfrancesco C; Desiato M; Perrone AM; Dondi G; De Iaco P; Ferrero S; Sarpietro G; Matarazzo MG; Cianci A; Cianci S; Bosio S; Ruisi S; Mosca L; Tinelli R; De Vincenzo R; Zannoni GF; Ferrandina G; Petrillo M; Capobianco G; Dessiole S; Carlea A; Zullo F; Muschiato B; Palomba S; Greggi S; Spinillo A; Ghezzi F; Colacurci N; Angioli R; Benedetti Panici P; Muzii L; Scambia G; Raspagliesi F; Di Donato V
Vaccines (Basel); 2022 Apr; 10(4):. PubMed ID: 35455328
[No Abstract] [Full Text] [Related]
15. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
16. Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)?
Kang WD; Choi HS; Kim SM
Gynecol Oncol; 2013 Aug; 130(2):264-8. PubMed ID: 23623831
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of human papillomavirus prophylactic vaccination after conization in preventing cervical intraepithelial neoplasia recurrence: A prospective observational study in China.
Chen M; Li C; Cui Q; Zhou C; Chen P; Yao S
Eur J Obstet Gynecol Reprod Biol; 2023 Jul; 286():10-15. PubMed ID: 37159990
[TBL] [Abstract][Full Text] [Related]
18. Distribution and role of high-risk human papillomavirus genotypes in women with cervical intraepithelial neoplasia: A retrospective analysis from Wenzhou, southeast China.
Wang Y; Xue J; Dai X; Chen L; Li J; Wu Y; Hu Y
Cancer Med; 2018 Jul; 7(7):3492-3500. PubMed ID: 29851256
[TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus Same Genotype Persistence and Risk of Cervical Intraepithelial Neoplasia2+ Recurrence.
Iacobone AD; Radice D; Sandri MT; Preti EP; Guerrieri ME; Vidal Urbinati AM; Pino I; Franchi D; Passerini R; Bottari F
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359566
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease.
Kreimer AR; Guido RS; Solomon D; Schiffman M; Wacholder S; Jeronimo J; Wheeler CM; Castle PE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):908-14. PubMed ID: 16702369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
